Therapeutic drug monitoring of ganciclovir for postnatal cytomegalovirus infection in an extremely low birth weight infant: A case report

BMC Pediatrics

Volumn 16, Issue 1, 2016, Pages

  Sunada, Mariko ^a   Kinoshita, Daisuke ^a   Furukawa, Naoko ^a   Kihara, Minako ^a   Nishimura, Akira ^a   Moriuchi, Masako ^b   Moriuchi, Hiroyuki ^b  

^a KYOTO FIRST RED CROSS HOSPITAL   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Extremely low birth weight infant; Ganciclovir; Postnatal cytomegalovirus infection; Therapeutic drug monitoring

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; GANCICLOVIR; HYDROCORTISONE; IMMUNOGLOBULIN; LUNG SURFACTANT; MEROPENEM; VANCOMYCIN; VIRUS DNA; ANTIVIRUS AGENT;

ABDOMINAL DISTENSION; AREA UNDER THE CURVE; ARTICLE; BILE DUCT ATRESIA; BILIARY TRACT DRAINAGE; BREAST MILK; CASE REPORT; CAUSE OF DEATH; CYTOMEGALOVIRUS INFECTION; DETERIORATION; DRUG BLOOD LEVEL; DRUG MONITORING; DRUG WITHDRAWAL; ENTERIC FEEDING; EXTREMELY LOW BIRTH WEIGHT; FEMALE; HEART SURGERY; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFANT; LIQUID CHROMATOGRAPHY; LIVER FAILURE; LIVER NECROSIS; NECROTIZING ENTEROCOLITIS; OBSTRUCTIVE JAUNDICE; PATENT DUCTUS ARTERIOSUS; PERINATAL PERIOD; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY DISTRESS; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INTUBATION; SEPSIS; TANDEM MASS SPECTROMETRY; THROMBOCYTOPENIA; VIRUS LOAD; CYTOMEGALOVIRUS INFECTIONS; DOSE RESPONSE; DRUG ADMINISTRATION; INFANT, PREMATURE, DISEASES; NEWBORN; PREMATURITY;

ANTIVIRAL AGENTS; AREA UNDER CURVE; CYTOMEGALOVIRUS INFECTIONS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; FEMALE; GANCICLOVIR; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, EXTREMELY PREMATURE; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; VIRAL LOAD;

EID: 84983085061     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/s12887-016-0683-x     Document Type: Article

References (9)

1. Dworsky M, Yow M, Stagno S, Pass RF, Alford C. Cytomegalovirus infection of breast milk and transmission in infancy. Pediatrics. 1983;72:295-9.
2. Maschmann J, Hamprecht K, Dietz K, Jahn G, Speer CP. Cytomegalovirus infection of extremely low-birth weight infants via breast milk. Clin Infect Dis. 2001;33:1998-2003.
3. Fischer C, Meylan P, Bickle Graz M, Gudinchet F, Vaudaux B, Berger C, et al. Severe postnatally acquired cytomegalovirus infection presenting with colitis, pneumonitis and sepsis-like syndrome in an extremely low birthweight infant. Neonatology. 2010;97:339-45.
4. Luck S, Lovering A, Griffiths P, Sharland M. Ganciclovir treatment in children: evidence of subtherapeutic levels. Int J Antimicrob Agents. 2011;37:445-8.
5. Piketty C, Bardin C, Gilquin J, Gairard A, Kazatchkine MD, Chast F. Monitoring plasma levels of ganciclovir in AIDS patients receiving oral ganciclovir as maintenance therapy for CMV retinitis. Clin Microbiol Infect. 2000;6:117-20.
6. Kimberlin DW, Lin CY, Sanchez PJ, Demmler GJ, Dankner W, Shelton M, et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003;143:16-25.
7. Nassetta L, Kimberlin D, Whitley R. Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies. J Antimicrob Chemother. 2009;63:862-7.
8. Kimberlin DW, Acosta EP, Sanchez PJ, Sood S, Agrawal V, Homans J, et al. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis. 2008;197:836-45.
9. Kadambari S, Williams EJ, Luck S, Griffiths PD, Sharland M. Evidence based management guidelines for the detection and treatment of congenital CMV. Early Hum Dev. 2011;87:723-8.